Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium lactate + calcium chloride + sodium chloride + potassium chloride + dextrose is a multi-ingredient intravenous crystalloid and carbohydrate solution marketed as Lactated Ringer's and Dextrose. It is an established hospital-use parenteral formulation used as a source of water, electrolytes, and calories and as an alkalinizing agent for replacement of extracellular fluid and electrolyte losses. Pharmacologically, its effect derives from physiologic electrolyte repletion, dextrose-mediated caloric support, and metabolism of lactate to bicarbonate, which can help buffer metabolic acidosis; it does not have a single discrete molecular target. The product has been manufactured by Hospira and is used in adults and pediatric patients in routine clinical care rather than as a targeted developmental asset.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium lactate + calcium chloride + sodium chloride + potassium chloride + dextrose.